Better Therapeutics, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 39.76 million compared to USD 40.34 million a year ago. Basic loss per share from continuing operations was USD 1.69 compared to USD 3.11 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0084 USD | +3.70% | -23.64% | -95.69% |
03-21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
03-20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-95.69% | 458K | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.09% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- BTTX Stock
- News Better Therapeutics, Inc.
- Better Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022